glyoxylate and hydroxypyruvate reductase
Dernière mise à jour 3 Apr 2025
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
La GRHPR gene provides instructions for making an enzyme called glyoxylate and hydroxypyruvate reductase. This enzyme plays a role in preventing the buildup of a potentially harmful substance called glyoxylate by converting it to a substance called glycolate, which is easily excreted from the body. Additionally, this enzyme can convert a compound called hydroxypyruvate to D-glycerate, which is eventually converted to the simple sugar glucose (by other enzymes) and used for energy.
Sélections vidéo pour GènesBibliothèque vidéo
Normal function
La GRHPR gene provides instructions for making an enzyme called glyoxylate and hydroxypyruvate reductase. This enzyme plays a role in preventing the buildup of a potentially harmful substance called glyoxylate by converting it to a substance called glycolate, which is easily excreted from the body. Additionally, this enzyme can convert a compound called hydroxypyruvate to D-glycerate, which is eventually converted to the simple sugar glucose (by other enzymes) and used for energy.
Conditions referring to this gene or chromosome
Other names
D-glycerate dehydrogenase
GLXR
glyoxylate reductase/hydroxypyruvate reductase
GRHPR_HUMAN
PH2
Related patient information and medicines

Patient information leaflet
Vérifiez vos médicaments pour les interactions
Use this vérificateur d'interactions médicamenteuses à see whether your medicines, supplements, vitamins, foods, or certain health conditions may interact with each other. It can help you understand potential risks, avoid unwanted side effects, and decide when it’s important to speak to a pharmacist, GP, or other healthcare professional. The tool is.

Patient information leaflet
Reflux acide et œsophagite
When acid from the stomach leaks up into the oesophagus (tube carrying the food from the mouth to the stomach) the condition is known as acid reflux. What is acid reflux. Dr Sarah Jarvis MBE, GP and Clinical Director of Patient.info When acid from the stomach leaks up into the gullet (oesophagus), the condition is known as acid reflux. This may.

Patient information leaflet
Hypertrophie de la prostate
Ceci l'hypertrophie de la prostate is also called benign prostatic hypertrophy (ou hyperplasia). It can cause problems with passing urine. Symptoms are often mild. Alpha-blocker medicines Alpha-blockers. These medicines work by relaxing the smooth muscle of the prostate and bladder neck. This can improve the flow of urine. 5-alpha reductase inhibitor.

Patient information leaflet
Syndrome de Sjögren
Syndrome de Sjögren est un autoimmune disease that causes the glands cela produce tears and saliva à stop working. It is a life-long condition but treatments can help control symptoms such as dry eyes and dry mouth. Key points Sjögren’s syndrome is an autoimmune condition where the immune system attacks glands that produce moisture, mainly the tear.

Patient information leaflet
Sang dans le sperme
Hématospermie means there is blood in the semen. Medicines If you have persistent haematospermia without an identified cause then a type of medicine called a Inhibiteur de la 5-alpha réductase tel que finasteride Finasteride for prostate gland enlargement or dutasteride Dutasteride for prostate gland enlargement may be effective. For younger men with.

Patient information leaflet
Problèmes de prostate
This leaflet will give you a brief explanation of the different prostate et urethral conditions and how the urine system can be affected. There are various treatments for the symptoms of BPH, including drugs such as alfuzosin/doxazosin (alpha-blockers), dutasteride/finasteride (5-alpha reductase inhibitors),.
Lectures complémentaires et références
- glyoxylate and hydroxypyruvate reductase; MedlinePlus, National Library of Medicine.
- Cochat P, Rumsby G. Primary hyperoxaluria. N Engl J Med. 2013 Aug 15;369(7):649-58. doi: 10.1056/NEJMra1301564. No abstract available.
- Cregeen DP, Williams EL, Hulton S, Rumsby G. Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2. Hum Mutat. 2003 Dec;22(6):497. doi: 10.1002/humu.9200.
- Hoppe B. An update on primary hyperoxaluria. Nat Rev Nephrol. 2012 Jun 12;8(8):467-75. doi: 10.1038/nrneph.2012.113.
- Knight J, Holmes RP. Mitochondrial hydroxyproline metabolism: implications for primary hyperoxaluria. Am J Nephrol. 2005 Mar-Apr;25(2):171-5. doi: 10.1159/000085409. Epub 2005 Apr 21.
- Rumsby G, Hulton SA. Primary Hyperoxaluria Type 2. 2008 Dec 2 [updated 2017 Dec 21]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK2692/
- Webster KE, Ferree PM, Holmes RP, Cramer SD. Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2). Hum Genet. 2000 Aug;107(2):176-85. doi: 10.1007/s004390000351.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

